Influence of progestin use on the IL-10 level in peritoneal endometriosis
article
OA: diamond
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study found that peritoneal endometriosis patients have higher IL-10 levels than controls, and progestin use significantly reduces these levels in peritoneal lavage.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Purpose: How can progestin influence the anti-inflammatory cytokine IL-10 level in the peritoneum with endometriosis? Methods: A cross-sectional study with a laboratory analysis carried out in tertiary hospitals in southern Brazil with clinical-demographic data compilation and sample collection of peritoneal lavage and a peritoneum biopsy from 40 patients — 22 with endometriosis (11 with progestin and 11 without it) and 18 in the control group — was conducted. For the sample analysis, the ELISA was performed, and a comparison of the average IL-10 concentrations by ANOVA followed by Bonferroni was carried out. Results: There was a higher concentration of IL-10 among patients with endometriosis compared to the control group (p ≤ 0.05), and statistical significance was observed with a reduction of IL-10 in the peritoneal lavage of patients with endometriosis in the use of progestin (8.1 ± 7.4 pg/ml) compared to those with endometriosis without using progestin (17.9 ± 10.5 pg/ml). Considering the disease stage, a higher level of IL-10 (p ≤ 0.05) was observed both in the initial stages (12.1 ± 10.5 pg/ml) and in advanced stages (15.4 ± 9.7 pg/ml) compared to the control (1.7 ± 1.8 pg/ml), which was significantly higher for advanced endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments via openalex
- Anatomic distribution of endometriosis: A reappraisal based on series of 1101 patients via openalex
- Annexin A1, FPR2/ALX, and inflammatory cytokine expression in peritoneal endometriosis via openalex
- Biomarkers in endometriosis: challenges and opportunities via openalex
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex
- Cytokines, Angiogenesis, and Extracellular Matrix Degradation are Augmented by Oxidative Stress in Endometriosis via openalex
- Deep Infiltrating Endometriosis and Activation and Memory Surface Markers and Cytokine Expression in Isolated Treg Cells via openalex
- Effect of Dienogest therapy on the size of the endometrioma via openalex
- Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months via openalex
- Endometriosis classification according to pain symptoms: can the ASRM classification be improved? via openalex
- Estrogen-progestins and progestins for the management of endometriosis via openalex
- IL‐10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis via openalex
- Immunology of endometriosis via openalex
- Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis via openalex
- Interleukin-15 and Interleukin-7 are the Major Cytokines to Maintain Endometriosis via openalex
- Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis via openalex
- Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines via openalex
- Pain Mechanisms in Peritoneal Diseases Might Be Partially Regulated by Estrogen via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women via openalex
- Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study via openalex
- Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis via openalex
- Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis via openalex
- The Impact of Endometriosis on Quality of Life in Adolescents via openalex
- The intricate role of mast cell proteases and the annexin A1-FPR1 system in abdominal wall endometriosis via openalex
- The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis via openalex
- Theories of endometriosis via openalex
- World Endometriosis Society consensus on the classification of endometriosis via openalex
- W2921506721 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK